ProVise Management Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,240
Closed -$421K 319
2019
Q3
$421K Hold
4,240
0.06% 214
2019
Q2
$392K Sell
4,240
-100
-2% -$9.5K 0.05% 226
2019
Q1
$409K Sell
4,340
-3,173
-42% -$277K 0.06% 209
2018
Q4
$482K Buy
7,513
+555
+8% +$41K 0.08% 196
2018
Q3
$623K Hold
6,958
0.08% 193
2018
Q2
$553 Sell
6,958
-11
-0.2% -$913 0.04% 207
2018
Q1
$622K Sell
6,969
-1,709
-20% -$164K 0.09% 180
2017
Q4
$906K Sell
8,678
-2,050
-19% -$231K 0.13% 148
2017
Q3
$1.56M Sell
10,728
-1,813
-14% -$247K 0.23% 112
2017
Q2
$1.63M Sell
12,541
-3,713
-23% -$455K 0.25% 108
2017
Q1
$2.02M Sell
16,254
-1,552
-9% -$186K 0.32% 92
2016
Q4
$2.06M Sell
17,806
-500
-3% -$55.7K 0.35% 90
2016
Q3
$1.91M Sell
18,306
-84
-0.5% -$9.09K 0.33% 88
2016
Q2
$1.81M Sell
18,390
-1,673
-8% -$173K 0.33% 92
2016
Q1
$2.01M Sell
20,063
-875
-4% -$90.1K 0.41% 71
2015
Q4
$2.51M Buy
20,938
+213
+1% +$24.6K 0.53% 55
2015
Q3
$2.24M Buy
20,725
+36
+0.2% +$4.47K 0.52% 58
2015
Q2
$2.4M Buy
20,689
+1,042
+5% +$119K 0.51% 54
2015
Q1
$2.27M Buy
19,647
+123
+0.6% +$14.7K 0.48% 60
2014
Q4
$2.18M Buy
19,524
+626
+3% +$66K 0.47% 64
2014
Q3
$1.79M Buy
18,898
+766
+4% +$69.1K 0.39% 78
2014
Q2
$1.56M Buy
18,132
+2,672
+17% +$203K 0.34% 92
2014
Q1
$1.08M Buy
15,460
+4,760
+44% +$377K 0.26% 105
2013
Q4
$904K Buy
10,700
+400
+4% +$31.7K 0.23% 124
2013
Q3
$794K Hold
10,300
0.22% 130
2013
Q2
$603K Buy
+10,300
New +$620K 0.18% 158

Other funds holding CELG

ProVise Management Group's CELG Position: Q4 2019 in Review

ProVise Management Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,240 shares — an estimated $421K sold.

ProVise Management Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.51M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ProVise Management Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ProVise Management Group sold 4,240 Celgene Corp shares in Q4 2019, an estimated $421K.
  • ProVise Management Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ProVise Management Group's Celgene Corp position peaked at $2.51M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ProVise Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.